Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study
Peter Gibbs, Val Gebski, Mark Van Buskirk, Kenneth Thurston, David N Cade, Guy A Van Hazel
BMC Cancer | BIOMED CENTRAL LTD | Published : 2014
This study was sponsored by Sirtex Technology Pty Ltd. The authors would like to acknowledge Bruce Gray for his involvement in the development of the initial protocol. We acknowledge the editorial assistance provided by Martin Gilmour of ESP Bioscience (Crowthorne, UK) funded by Sirtex, during the preparation of this manuscript.